Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 1
2003 3
2004 8
2005 1
2006 10
2007 20
2008 12
2009 10
2010 8
2011 8
2012 3
2013 5
2014 2
2015 1
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 20628086

85 results
Results by year
Filters applied: . Clear all
Page 1
Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study.
Bailey SD, Xie C, Do R, Montpetit A, Diaz R, Mohan V, Keavney B, Yusuf S, Gerstein HC, Engert JC, Anand S; DREAM investigators. Bailey SD, et al. Diabetes Care. 2010 Oct;33(10):2250-3. doi: 10.2337/dc10-0452. Epub 2010 Jul 13. Diabetes Care. 2010. PMID: 20628086 Free PMC article.
[DREAM study: prevention of type 2 diabetes with ramipril and/or rosiglitazone in persons with dysglycaemia but no cardiovascular desease].
Scheen AJ. Scheen AJ. Rev Med Liege. 2006 Oct;61(10):728-32. Rev Med Liege. 2006. PMID: 17209507 Free article. Clinical Trial. French.
[Influence of diabetes incidence by ramipril and rosiglitazone: DREAM study (diabetes reduction assessment with ramipril and rosiglitazone medication)].
Standl E, Nitschmann S. Standl E, et al. Internist (Berl). 2007 Oct;48(10):1173-6. doi: 10.1007/s00108-007-1932-8. Internist (Berl). 2007. PMID: 17846732 German. No abstract available.
Incidence of diabetes following ramipril or rosiglitazone withdrawal.
DREAM Trial Investigators. DREAM Trial Investigators. Diabetes Care. 2011 Jun;34(6):1265-9. doi: 10.2337/dc10-1567. Epub 2011 Apr 22. Diabetes Care. 2011. PMID: 21515846 Free PMC article. Clinical Trial.
Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
DREAM Trial Investigators, Dagenais GR, Gerstein HC, Holman R, Budaj A, Escalante A, Hedner T, Keltai M, Lonn E, McFarlane S, McQueen M, Teo K, Sheridan P, Bosch J, Pogue J, Yusuf S. DREAM Trial Investigators, et al. Diabetes Care. 2008 May;31(5):1007-14. doi: 10.2337/dc07-1868. Epub 2008 Feb 11. Diabetes Care. 2008. PMID: 18268075 Clinical Trial.
Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trial.
Hanley AJ, Zinman B, Sheridan P, Yusuf S, Gerstein HC; Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Investigators. Hanley AJ, et al. Diabetes Care. 2010 Mar;33(3):608-13. doi: 10.2337/dc09-1579. Epub 2009 Dec 15. Diabetes Care. 2010. PMID: 20009095 Free PMC article. Clinical Trial.
Diabetes prevention between RAAS inhibition and PPAR-gamma stimulation: the diabetes reduction assessment with ramipril and rosiglitazone medication (DREAM) trial.
McFarlane SI, Provilus A, Shin JJ. McFarlane SI, et al. J Cardiometab Syndr. 2007 Spring;2(2):149-50. doi: 10.1111/j.1559-4564.2007.06663.x. J Cardiometab Syndr. 2007. PMID: 17684471 Clinical Trial. No abstract available.
Effect of rosiglitazone/ramipril on preclinical vasculopathy in newly diagnosed, untreated diabetes and IGT patients: 1-year randomised, double-blind, placebo-controlled study.
Rahman S, Ismail AA, Ismail SB, Naing NN, Abdul Rahman AR. Rahman S, et al. Eur J Clin Pharmacol. 2007 Aug;63(8):733-41. doi: 10.1007/s00228-007-0315-3. Epub 2007 Jun 13. Eur J Clin Pharmacol. 2007. PMID: 17565489 Clinical Trial.
Effects of ethnicity on diabetes incidence and prevention: results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial.
Boyko EJ, Gerstein HC, Mohan V, Yusuf S, Sheridan P, Anand S, Shaw JE; DREAM trial investigators. Boyko EJ, et al. Diabet Med. 2010 Nov;27(11):1226-32. doi: 10.1111/j.1464-5491.2010.03064.x. Diabet Med. 2010. PMID: 20950379 Clinical Trial.
Genetic predisposition and nongenetic risk factors of thiazolidinedione-related edema in patients with type 2 diabetes.
Chang TJ, Liu PH, Liang YC, Chang YC, Jiang YD, Li HY, Lo MT, Chen HS, Chuang LM. Chang TJ, et al. Pharmacogenet Genomics. 2011 Dec;21(12):829-36. doi: 10.1097/FPC.0b013e32834bfff1. Pharmacogenet Genomics. 2011. PMID: 21934636
85 results
Jump to page
Feedback